Bodal Chemicals Limited

BSE:524370 Stock Report

Market Cap: ₹9.3b

Bodal Chemicals Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Bodal Chemicals.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth19.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Narrative Update • Mar 03

524370: Future Returns Will Rise As Upcoming Board Results Support Earnings Confidence

Analysts have nudged their price target on Bodal Chemicals to ₹107, reflecting slightly higher assumptions for revenue growth and future P/E, partly offset by a modest trim to profit margin expectations and a small adjustment to the discount rate. What's in the News A board meeting is scheduled for Feb 14, 2026 to consider and approve standalone unaudited financial results for the quarter and nine months ended Dec 31, 2025.
Narrative Update • Feb 17

524370: Future Returns Will Rise As Board Meeting Supports Earnings Confidence

Analysts have reset their price target on Bodal Chemicals to ₹107, reflecting updated views on the discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News A board meeting is scheduled for February 14, 2026 to review and approve standalone unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Narrative Update • Feb 02

524370: Future Returns Will Rise As Board Review Supports Earnings Confidence

Analysts have reiterated their fair value estimate for Bodal Chemicals at ₹107.0, with only small tweaks to inputs like the discount rate and future P/E assumptions. The headline target remains unchanged, while reflecting updated model fine tuning.
Narrative Update • Jan 19

524370: Future Returns Will Rise As Stable Assumptions Support Earnings Confidence

Analysts have maintained their fair value estimate for Bodal Chemicals at ₹107.0, with only small adjustments to inputs such as the discount rate and future P/E assumptions. This signals that their overall view on the stock's price target is broadly unchanged.
Narrative Update • Jan 05

524370: Future Returns Will Rise As Lower Risk Supports Earnings Confidence

Analysts have modestly revised their price target for Bodal Chemicals upward to ₹107.00, reflecting slightly lower perceived risk and marginally improved confidence in the company’s long term earnings profile. What's in the News A board meeting is scheduled on November 12, 2025, to review and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025 (company filing).
Narrative Update • Dec 20

524370: Future Returns Will Benefit From Lower Risk And Stable Profit Margins

Analysts have modestly increased their price target on Bodal Chemicals to reflect a fair value of ₹107.00 per share, highlighting slightly lower perceived risk and stable expectations for revenue growth, margins, and future earnings multiples. What's in the News Board meeting scheduled for November 12, 2025, to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, and to take up any other business (company filing) Shareholders approved the appointment of M/s.
Narrative Update • Dec 06

524370: Future Returns Will Benefit From Stable Margins And Modest Multiple Expansion

Analysts have nudged their price target on Bodal Chemicals slightly higher to ₹107.0 per share from ₹107, reflecting a marginally increased discount rate and modestly higher expectations for the company’s future valuation multiples while keeping growth and margin assumptions broadly unchanged. What's in the News A board meeting is scheduled for November 12, 2025 to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, and to take up any other business (Key Developments).
Narrative Update • Nov 22

524370: Future Results Will Benefit From Rising Profit Margins And Sustained Revenue Momentum

Analysts have maintained their price target for Bodal Chemicals at ₹107.00, citing slightly improved profit margin and revenue growth outlooks. These factors offset a modest increase in the discount rate and a lower estimated future price-to-earnings ratio.
Narrative Update • Nov 06

524370: Future Results Will Benefit From Lower Discount Rate And Steady Profitability

Narrative Update: Bodal Chemicals Analyst Price Target Revision Analysts have maintained their price target for Bodal Chemicals at ₹107.00. They stated that minor adjustments to the discount rate and forward-looking estimates were not significant enough to warrant a change in valuation.
Narrative Update • Oct 22

Analysts Raise Bodal Chemicals Price Target as Profit Margin Forecast Improves Amid Company Updates

Analysts have raised their price target for Bodal Chemicals from ₹92.5 to ₹107.0. This reflects improved profit margin forecasts, despite slightly lower revenue growth expectations. What's in the News Bodal Chemicals approved the appointment of M/s.
User avatar
New Narrative • Feb 18

Saykha Benzene Project Nearing Viability Will Strengthen Future Prospects

Expansion into benzene downstream and salt-free dyes is set to boost revenue and margins, leveraging existing resources efficiently.

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bodal Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BSE:524370 - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202620,5394781,4021,760N/A
12/31/202518,716303N/AN/AN/A
9/30/202518,255354369796N/A
6/30/202517,772292N/AN/AN/A
3/31/202517,4491856731,138N/A
12/31/202416,87660N/AN/AN/A
9/30/202415,827169372,131N/A
6/30/202414,84131N/AN/AN/A
3/31/202413,94665-4072,042N/A
12/31/202313,90672N/AN/AN/A
9/30/202313,82187-3482,192N/A
6/30/202314,440177N/AN/AN/A
3/31/202315,743380-4792,899N/A
12/31/202217,678676N/AN/AN/A
9/30/202220,138896-2,1571,101N/A
6/30/202220,8781,030N/AN/AN/A
3/31/202220,5531,042-1,726-135N/A
12/31/202118,8611,004N/AN/AN/A
9/30/202116,9041,052-2,713-355N/A
6/30/202115,304916N/AN/AN/A
3/31/202112,264420-1,911-130N/A
12/31/202011,622418N/AN/AN/A
9/30/202011,2242976771,198N/A
6/30/202011,204406N/AN/AN/A
3/31/202013,748872-42596N/A
12/31/201913,506941N/AN/AN/A
9/30/201913,5861,091N/A115N/A
6/30/201914,4411,323N/AN/AN/A
3/31/201914,2351,432N/A1,860N/A
12/31/201813,7251,528N/AN/AN/A
9/30/201813,4541,527N/AN/AN/A
6/30/201812,0831,321N/AN/AN/A
3/31/201811,4221,226N/A71N/A
3/31/201712,3441,329N/A1,036N/A
3/31/20169,078860N/A1,312N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 524370's forecast earnings growth is above the savings rate (6.9%).

Earnings vs Market: Insufficient data to determine if 524370's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if 524370's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 524370's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if 524370's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 524370's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/25 08:31
End of Day Share Price 2026/05/22 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bodal Chemicals Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nikhil ShettyBP Wealth Management Private Limited
Anil BurraFirstCall Research
Chirag ShahICICIdirect.com